PedAM
Pediatric Disease Annotations & Medicines
| Disease | acne |
| Phenotype | C0032460|polycystic ovarian syndrome |
| Sentences | 1 |
| PubMedID- 22208934 | Another likely explanation in the recent literature is that drospirenone and spironolactone are both seen as beneficial for treatment of weight gain and bloating experienced by patients with postmenstrual dysphoric disorder and in reducing hirsutism and acne in patients with polycystic ovarian syndrome (pcos) [24-28]. |
Page: 1